<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>358</id><JournalTitle>A SYSTEMATIC REVIEW OF ATLANTIA MONOPHYLLA: PHYTOCHEMISTRY, PHARMACOLOGY, TOXICITY, AND THERAPEUTIC POTENTIAL</JournalTitle><Abstract>Atlantia monophylla (L.) Correa, a member of the Rutaceae family, is a medicinal plant widely distributed in South and
Southeast Asia and traditionally utilized for the treatment of various ailments including infections, inflammation, and
metabolic disorders. In recent years, increasing scientific attention has been directed toward understanding the phytochemical
composition and pharmacological properties of this plant. The present systematic review aims to comprehensively
summarize the available literature on the phytochemistry, pharmacological activities, toxicity profile, and emerging
therapeutic potential of Atlantia monophylla. Extensive studies have identified a wide range of bioactive constituents such as
flavonoids, alkaloids, phenolic compounds, coumarins, terpenoids, and essential oils in different parts of the plant. These
phytochemicals contribute to diverse biological activities including antioxidant, antimicrobial, anti-inflammatory,
antidiabetic, and anticancer effects. Experimental investigations have demonstrated that extracts and isolated compounds
from A. monophylla exhibit significant free radical scavenging activity, inhibition of pathogenic microorganisms, and
modulation of inflammatory pathways. In addition, certain alkaloids and flavonoids isolated from the plant have shown
promising cytotoxic activity against cancer cell lines, suggesting potential applications in oncology research. Toxicological
evaluations indicate that plant extracts are relatively safe at moderate doses; however, further detailed safety assessments and
clinical investigations are required. Recent advances in nanotechnology have also opened new opportunities for enhancing
the therapeutic efficacy of A. monophylla phytochemicals through nanoparticle-based drug delivery systems, which may
improve bioavailability, stability, and targeted delivery. Overall, the available evidence highlights the significant
pharmacological potential of Atlantia monophylla and underscores the need for further mechanistic studies, isolation of novel
compounds, and well-designed clinical trials to fully explore its therapeutic applications in modern medicine</Abstract><Email>mohanrajk7k@gmail.com</Email><articletype>Research</articletype><volume>16</volume><issue>2</issue><year>2026</year><keyword>Atlantia monophylla; Phytochemistry; Pharmacological activities; Antioxidant activity; Nanotechnology</keyword><AUTHORS>Mohan Raj1*, Swaranalatha S2, Karthik J</AUTHORS><afflication>1Department of Pharmacology, Pallavan College of Pharmacy, Kancheepuram, Tamil Nadu, India. 2Professor and HOD, Department of Pharmacology, Pallavan College of Pharmacy, Kancheepuram, Tamil Nadu, India. 3Principal, Pallavan College of Pharmacy, Kancheepuram, Tamil Nadu, India</afflication></Article></Articles>